|
Market Closed -
Other stock markets
|
After hours 05:30:00 am | |||
| 985.08 USD | +0.80% |
|
985.00 | -0.01% |
| 14/03 | Healthcare Stocks Post Small Losses -- Healthcare Roundup | DJ |
| 13/03 | The Kroger Co Brings Zepbound KwikPen To Retail Pharmacy Expanding Access And Savings For Self-Pay Patients | CI |
Chart calendar Eli Lilly and Company
Upcoming events on Eli Lilly and Company
| 30/04/2026 | Earnings presentation | 07:30 pm |
| 30/04/2026 | Estimated Earnings Release Date (S&P Global Derived) - Q1 2026 | ~ 10:00 pm |
| 04/05/2026 | Annual General Meeting | Day |
| 05/08/2026 | Earnings presentation | 07:30 pm |
| 29/10/2026 | Earnings presentation | 07:30 pm |
Past events on Eli Lilly and Company
| 04/02/2026 | Earnings presentation | 08:30 pm |
| 04/02/2026 | Earnings release - Q4 2025 | ~ 11:00 pm |
| 30/10/2025 | Earnings presentation | 07:30 pm |
| 30/10/2025 | Earnings release - Q3 2025 | ~ 10:00 pm |
| 07/08/2025 | Earnings presentation | 06:00 pm |
| 07/08/2025 | Earnings release - Q2 2025 | ~ 10:00 pm |
| 23/06/2025 | Information meeting | 05:00 am |
| 05/05/2025 | Annual General Meeting | 06:00 pm |
| 05/05/2025 | Présentation aux Actionnaires / Analystes | 06:00 pm |
| 01/05/2025 | Earnings presentation | 07:30 pm |
| 01/05/2025 | Earnings release - Q1 2025 | ~ 10:00 pm |
Past dividends on Eli Lilly and Company
| 13/02/2026 | Ex-dividend date - 1.73 USD | 10:30 am |
| 14/11/2025 | Ex-dividend date - 1.5 USD | 10:30 am |
| 15/08/2025 | Ex-dividend date - 1.5 USD | 09:30 am |
| 16/05/2025 | Ex-dividend date - 1.5 USD | 09:30 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 34 124 33 585 1.6% | 45 043 45 075 -0.07% | 65 179 63 861 2.06% | 82 112 | 94 797 | 107 357 |
|
EBITDA Million USD | Released Forecast Spread | 8 584 8 418 1.98% | 16 079 16 083 -0.02% | 29 271 28 808 1.61% | 40 881 | 48 433 | 56 836 |
|
EBIT Million USD | Released Forecast Spread | 7 057 6 928 1.86% | 14 313 14 193 0.84% | 27 274 26 479 3% | 38 384 | 45 307 | 53 072 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 555 6 311 3.86% | 12 680 14 139 -10.32% | 25 731 24 869 3.46% | 37 263 | 43 043 | 50 207 |
|
Net income Million USD | Released Forecast Spread | 5 240 5 307 -1.26% | 10 590 11 007 -3.78% | 20 640 20 124 2.57% | 30 392 | 36 201 | 42 852 |
|
EPS USD | Released Forecast Spread | 5,80 6,04 -3.92% | 11,7 12,3 -4.87% | 23,0 22,5 1.78% | 34,0 | 40,2 | 48,3 |
| Announcement Date | 06/02/24 | 06/02/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11 303 9 968 13.4% | 11 439 12 119 -5.61% | 13 533 13 431 0.76% | 12 729 12 722 0.05% | 15 558 14 669 6.06% | 17 601 16 069 9.53% | 19 292 17 944 7.51% | 17 612 | 19 556 | 21 220 | 23 496 | 21 045 | 22 825 | 23 530 | 24 390 |
|
EBITDA Million USD | Released Forecast Spread | 4 703 3 848 22.22% | 2 214 2 501 -11.48% | 6 113 6 205 -1.48% | 4 316 5 052 -14.58% | 7 467 6 892 8.35% | 8 320 7 087 17.39% | 9 167 8 429 8.75% | 8 526 | 9 768 | 10 879 | 11 660 | ||||
|
EBIT Million USD | Released Forecast Spread | 4 289 3 028 41.63% | 1 747 2 347 -25.55% | 5 628 5 532 1.74% | 3 853 4 172 -7.65% | 6 989 6 178 13.13% | 7 850 6 531 20.2% | 8 581 7 562 13.48% | 7 910 | 9 009 | 10 098 | 11 261 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3 517 3 065 14.75% | 1 588 | 5 039 5 429 -7.19% | 3 456 5 074 -31.89% | 6 776 5 688 19.14% | 7 232 6 874 5.21% | 8 265 7 685 7.55% | 7 934 | 8 793 | 9 506 | 10 667 | ||||
|
Net income Million USD | Released Forecast Spread | 2 967 2 415 22.87% | 970 1 177 -17.58% | 4 410 4 600 -4.13% | 2 759 3 322 -16.94% | 5 661 4 833 17.13% | 5 583 5 299 5.34% | 6 636 6 270 5.83% | 6 330 | 7 258 | 8 059 | 8 899 | ||||
|
EPS USD | Released Forecast Spread | 3,28 2,72 20.64% | 1,07 1,54 -30.7% | 4,88 5,01 -2.59% | 3,06 4,11 -25.6% | 6,29 5,50 14.46% | 6,21 5,93 4.66% | 7,39 7,04 5.01% | 7,13 | 8,13 | 9,03 | 9,83 | ||||
| Announcement Date | 08/08/24 | 30/10/24 | 06/02/25 | 01/05/25 | 07/08/25 | 30/10/25 | 04/02/26 | - | - | - | - | - | - | - | - |
| 16/03/2026 | Ex-dividend date - 0.85 USD | 09:30 am | |
| 16/03/2026 | Annual General Meeting | 08:30 pm | |
| 16/03/2026 | Présentation aux Actionnaires / Analystes | 08:30 pm | |
| 16/03/2026 | Annual General Meeting | 08:30 pm | |
| 16/03/2026 | Board of Directors Meeting | Day | |
| 16/03/2026 | Earnings release - Annual 2025 | ~ 10:00 am | |
| 16/03/2026 | Extraordinary General Meeting | 12:00 pm | |
| 16/03/2026 | Extraordinary General Meeting | 01:00 pm | |
| 17/03/2026 | Ex-dividend date - 1.6 DKK | 09:30 am | |
| 17/03/2026 | Earnings release - Annual 2025 | 10:00 pm |
Past sector events for Eli Lilly and Company
| 13/03/2026 | Ex-dividend date - 0.82 USD | 09:30 am | |
| 13/03/2026 | Présentation aux Actionnaires / Analystes | 06:30 am | |
| 13/03/2026 | Présentation aux Actionnaires / Analystes | Day | |
| 13/03/2026 | Board of Directors Meeting | Day | |
| 13/03/2026 | Earnings presentation | Day | |
| 13/03/2026 | Earnings release - Annual 2025 | ~ 12:30 pm | |
| 13/03/2026 | Earnings presentation | Day | |
| 13/03/2026 | Extraordinary General Meeting | 12:30 pm | |
| 13/03/2026 | Extraordinary General Meeting | 11:30 am | |
| 12/03/2026 | Ex-dividend date - 9.8 CHF | 09:30 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LLY Stock
- Calendar Eli Lilly and Company
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















